ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/06 | 1,941 | 2,025 | 1,916 | 1,920 | +47 | +2.5% | 194,100 |
2019/02/05 | 1,852 | 1,899 | 1,852 | 1,873 | +25 | +1.4% | 101,900 |
2019/02/04 | 1,805 | 1,849 | 1,805 | 1,848 | +39 | +2.2% | 88,400 |
2019/02/01 | 1,805 | 1,827 | 1,801 | 1,809 | +10 | +0.6% | 81,700 |
2019/01/31 | 1,822 | 1,836 | 1,790 | 1,799 | -8 | -0.4% | 208,100 |
2019/01/30 | 1,831 | 1,841 | 1,803 | 1,807 | -34 | -1.8% | 151,700 |
2019/01/29 | 1,828 | 1,843 | 1,802 | 1,841 | +5 | +0.3% | 116,700 |
2019/01/28 | 1,845 | 1,854 | 1,823 | 1,836 | -10 | -0.5% | 95,400 |
2019/01/25 | 1,869 | 1,883 | 1,842 | 1,846 | -17 | -0.9% | 108,300 |
2019/01/24 | 1,892 | 1,892 | 1,858 | 1,863 | -40 | -2.1% | 129,400 |
2019/01/23 | 1,931 | 1,931 | 1,898 | 1,903 | -50 | -2.6% | 91,900 |
2019/01/22 | 1,973 | 1,983 | 1,946 | 1,953 | -1 | -0.1% | 114,500 |
2019/01/21 | 1,949 | 1,970 | 1,940 | 1,954 | +5 | +0.3% | 97,800 |
2019/01/18 | 1,943 | 1,967 | 1,925 | 1,949 | +4 | +0.2% | 67,700 |
2019/01/17 | 1,929 | 1,947 | 1,902 | 1,945 | +17 | +0.9% | 139,700 |
2019/01/16 | 1,938 | 1,960 | 1,917 | 1,928 | -4 | -0.2% | 117,000 |
2019/01/15 | 1,928 | 1,936 | 1,895 | 1,932 | -9 | -0.5% | 148,000 |
2019/01/11 | 1,945 | 1,948 | 1,925 | 1,941 | ±0 | ±0% | 107,000 |
2019/01/10 | 1,955 | 1,971 | 1,937 | 1,941 | -15 | -0.8% | 103,400 |
2019/01/09 | 1,957 | 1,978 | 1,943 | 1,956 | +5 | +0.3% | 103,900 |
2019/01/08 | 1,953 | 1,955 | 1,921 | 1,951 | +2 | +0.1% | 162,700 |
2019/01/07 | 2,000 | 2,000 | 1,935 | 1,949 | +20 | +1% | 101,900 |
2019/01/04 | 1,933 | 1,944 | 1,895 | 1,929 | -44 | -2.2% | 118,200 |
2018/12/28 | 1,980 | 1,991 | 1,960 | 1,973 | -2 | -0.1% | 70,100 |
2018/12/27 | 1,927 | 1,988 | 1,923 | 1,975 | +94 | +5% | 121,400 |
2018/12/26 | 1,883 | 1,929 | 1,865 | 1,881 | +2 | +0.1% | 125,200 |
2018/12/25 | 1,936 | 1,936 | 1,859 | 1,879 | -97 | -4.9% | 172,400 |
2018/12/21 | 1,967 | 1,985 | 1,928 | 1,976 | +17 | +0.9% | 212,400 |
2018/12/20 | 2,005 | 2,014 | 1,945 | 1,959 | -45 | -2.2% | 213,000 |
2018/12/19 | 1,997 | 2,023 | 1,985 | 2,004 | +7 | +0.4% | 170,200 |
2018/12/18 | 2,000 | 2,010 | 1,992 | 1,997 | -11 | -0.5% | 199,600 |
2018/12/17 | 2,012 | 2,021 | 1,990 | 2,008 | ±0 | ±0% | 145,300 |
2018/12/14 | 1,999 | 2,031 | 1,993 | 2,008 | -6 | -0.3% | 123,100 |
2018/12/13 | 2,037 | 2,039 | 2,007 | 2,014 | -6 | -0.3% | 75,000 |
2018/12/12 | 1,963 | 2,027 | 1,963 | 2,020 | +76 | +3.9% | 108,400 |
2018/12/11 | 2,004 | 2,004 | 1,930 | 1,944 | -65 | -3.2% | 168,400 |
2018/12/10 | 2,016 | 2,023 | 1,999 | 2,009 | -23 | -1.1% | 81,100 |
2018/12/07 | 2,019 | 2,036 | 2,001 | 2,032 | +21 | +1% | 87,800 |
2018/12/06 | 2,003 | 2,018 | 1,981 | 2,011 | -25 | -1.2% | 133,200 |
2018/12/05 | 2,011 | 2,052 | 2,002 | 2,036 | +3 | +0.1% | 106,700 |
2018/12/04 | 2,103 | 2,105 | 2,031 | 2,033 | -71 | -3.4% | 140,400 |
2018/12/03 | 2,120 | 2,130 | 2,084 | 2,104 | ±0 | ±0% | 87,700 |
2018/11/30 | 2,069 | 2,119 | 2,058 | 2,104 | +38 | +1.8% | 111,300 |
2018/11/29 | 2,092 | 2,092 | 2,057 | 2,066 | -20 | -1% | 102,600 |
2018/11/28 | 2,078 | 2,092 | 2,059 | 2,086 | +8 | +0.4% | 76,200 |
2018/11/27 | 2,102 | 2,103 | 2,069 | 2,078 | -24 | -1.1% | 64,300 |
2018/11/26 | 2,109 | 2,111 | 2,077 | 2,102 | -7 | -0.3% | 60,800 |
2018/11/22 | 2,078 | 2,113 | 2,065 | 2,109 | +32 | +1.5% | 51,200 |
2018/11/21 | 2,075 | 2,094 | 2,058 | 2,077 | -25 | -1.2% | 90,700 |
2018/11/20 | 2,097 | 2,106 | 2,077 | 2,102 | +5 | +0.2% | 48,700 |
1601~
1650
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム